Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Sels

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Obesity (2005)|February 21, 2007
Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitusM Mensink, M K C Hesselink, A P Russell, et al.
British Journal of Clinical Pharmacology|October 1, 1996
Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteersJ P Sels, J J Nauta, P P Menheere, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 11, 1992
[Effects of dietary fiber and insulin treatment on serum levels of lipids and lipoprotein (a) in patients with type II diabetes mellitus]B H Wolffenbuttel, J P Sels, B J Heesen, et al.
Diabetes Care|December 1, 1996
Comparison of different insulin regimens in elderly patients with NIDDMB H Wolffenbuttel, J P Sels, G J Rondas-Colbers, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDMB H Wolffenbuttel, L Nijst, J P Sels, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 15, 1991
[The effects of insulin combined with glibenclamide on glucose and lipid metabolism in patients with Type II diabetes mellitus]B H Wolffenbuttel, G J Rondas-Colbers, P P Menheere, et al.
The Netherlands Journal of Medicine|June 1, 1992
Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicityB H Wolffenbuttel, P P Menheere, L Nijst, et al.
The Netherlands Journal of Medicine|June 1, 1994
Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitusJ P Sels, P J Kingma, B H Wolffenbuttel, et al.
Diabetes Research and Clinical Practice|September 1, 1991
Clinical characteristics and management of diabetic patients residing in a nursing homeB H Wolffenbuttel, S van Vliet, A J Knols, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1993
Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levelsB H Wolffenbuttel, P B Leurs, J P Sels, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Obesity (2005)|February 21, 2007
Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitusM Mensink, M K C Hesselink, A P Russell, et al.
British Journal of Clinical Pharmacology|October 1, 1996
Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteersJ P Sels, J J Nauta, P P Menheere, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 11, 1992
[Effects of dietary fiber and insulin treatment on serum levels of lipids and lipoprotein (a) in patients with type II diabetes mellitus]B H Wolffenbuttel, J P Sels, B J Heesen, et al.
Diabetes Care|December 1, 1996
Comparison of different insulin regimens in elderly patients with NIDDMB H Wolffenbuttel, J P Sels, G J Rondas-Colbers, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDMB H Wolffenbuttel, L Nijst, J P Sels, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 15, 1991
[The effects of insulin combined with glibenclamide on glucose and lipid metabolism in patients with Type II diabetes mellitus]B H Wolffenbuttel, G J Rondas-Colbers, P P Menheere, et al.
The Netherlands Journal of Medicine|June 1, 1992
Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicityB H Wolffenbuttel, P P Menheere, L Nijst, et al.
The Netherlands Journal of Medicine|June 1, 1994
Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitusJ P Sels, P J Kingma, B H Wolffenbuttel, et al.
Diabetes Research and Clinical Practice|September 1, 1991
Clinical characteristics and management of diabetic patients residing in a nursing homeB H Wolffenbuttel, S van Vliet, A J Knols, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1993
Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levelsB H Wolffenbuttel, P B Leurs, J P Sels, et al.
Pageof 4